Aiforia and Paige form strategic partnership to advance AI integration in pathology laboratories

Aiforia, a trusted provider of deep learning artificial intelligence (AI) solutions for pathology and Paige, a leader in next-generation AI technology have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI* applications in the Aiforia® Platform to provide customers with outstanding functionality and performance.

Aiforia, a trusted provider of deep learning artificial intelligence (AI) solutions for pathology and Paige, a leader in next-generation AI technology have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI* applications in the AiforiaⓇ Platform to provide customers with outstanding functionality and performance. The partnership includes joint commercial efforts and enables both companies to provide their customers with top-tier AI-powered workflows aimed at enhancing laboratory efficiency, diagnostic confidence, scientific discoveries, and patient care results.

“Paige is delighted to partner with Aiforia, as this will further strengthen our combined leadership in the pathology industry, drive adoption in life sciences and diagnostics and make our powerful AI solutions available to more patients.” says Peter Hamilton, GM of Diagnostics at Paige.

“This collaboration marks a milestone in our dedication to providing powerful AI-solutions that address the changing needs of pathology laboratories. Paige has been with us at the forefront of AI in pathology diagnostics, and integrating our solutions into a joint offering presents a compelling opportunity for both us and our clients,” says Jukka Tapaninen, CEO of Aiforia. 

The collaboration will begin in the coming months by creating seamlessly integrated solutions for both clinical and preclinical laboratory workflows, and will also include product development initiatives around foundation models. 

——

*Not intended to replace licensed medical professional diagnosis. In the US: For Research Use Only. Not for use in diagnostic procedures.

View Press Release 

Previous
Previous

PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System

Next
Next

Gestalt and Paige Partner to Enhance Digital Pathology Workflows with Integration of Advanced AI Algorithms